GHRP-2 5mg
GHRP-2 is a synthetic hexapeptide (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂) that acts as a potent growth hormone secretagogue.
GHRP-2 is a synthetic hexapeptide (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂) that acts as a potent growth hormone secretagogue.
Browse nearby entries from the full catalog, starting with Purchase Peptides.
Start with adjacent compounds, or send one straight to the assistant for a comparison prompt.
Ask AssistantGHRP-2 is a synthetic hexapeptide (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂) that acts as a potent growth hormone secretagogue. It binds to the ghrelin receptor (GHS-R1a) to activate Gq/PLC- and calcium-mediated signaling pathways, thereby promoting modulation of the GH axis in preclinical studies. GHRP-2 is used in endocrinology and receptor biology research to investigate peptide-induced growth hormone regulation and hypothalamic–pituitary communication pathways.
GHRP-2 (also known as Pralmorelin) is a synthetic growth hormone secretagogue, known to bind to the ghrelin- or growth hormone secretagogue receptor (GHSR). It is described in the literature as the first member of this group of substances and is marketed as a test peptide for the assessment of a growth hormone deficiency and secondary adrenal insufficiency.
GHRP-2 has also been studied in Phase II studies for dwarfism and remains a subject of research regarding its effects on appetite, muscle growth, immune function, and sleep cycles. The source text states that GHRP-2 is active orally and sublingually.
Jump from this product into the newest URLs, recent updates, and grouped hubs.
Short-acting GHRH analog + GHSR agonist in one vial for studying pituitary axis coordination.
Synthetic fraction of the protein thymosin beta-4, used to investigate actin polymerization and cell migration in recovery contexts.
5-amino-1MQ is a small-molecule research compound that acts as a selective nicotinamide-N-methyltransferase (NNMT) inhibitor.
Acetyl Hexapeptide-3 (Argireline) is a hexapeptide analogue of SNAP-25 (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂), developed to modulate vesicle docking and the release of catecholamines by inhibiting SNARE complex formation.
The definitive guide to peptide legality — covering BPC-157, TB-500, and other research peptides. What's legal, what's restricted, and what's changing in 2025-2026.
Comprehensive guide to BPC-157 dosing — injection, oral, and nasal protocols. How to reconstitute, calculate doses, and structure your cycle based on commonly reported approaches.
Supporting documents typically expected alongside the product profile.
This page is compiled from publicly available research material and normalized for browsing inside the catalog.